Definitive Contract 75A50121C00076
Award Date
9/7/21
Potential Completion Date
6/16/23
Potential Value
$719K
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $60,702,067.00 cost-plus-fixed-fee contract to The Charles Stark Draper Laboratory, Inc. (Draper) to advance the development of a medical countermeasure (MCM) evaluation platform. The platform will consist of vascular-immune and small intestine-immune organ-on-chip models, molecular assays, omics-based technologies, and advanced analytical methods for biomarker...
This is a $749,095 firm fixed-price federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response to The Charles Stark Draper Laboratory, Inc. (doing business as Draper), a not-for-profit research and development organization. The contract, which does not have a set-aside designation, is for the development of a "bioinspired microfluidic oxygenator for long duration ECMO without anticoagulation." Draper has extensive experience as both a prime...
This is a $1,280,851.00 definitive contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to The Charles Stark Draper Laboratory, Inc. (Draper) to obtain a high-throughput flow system (HTFS) capable of exerting physiological shear stresses on human endothelial cell monolayers growing on a membrane bilayer similar to transwell inserts in a 96-well plate, cultured with astrocytes on...
This is a $749,795.91 firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lungpacer Medical USA Inc. for the "LUNGPACER MEDICAL USA INC LUNG-PROTECTIVE EFFECTS OF TRANSVENOUS DIAPHRAGM ACTIVATION IN PATIENTS WITH ARDS AOI #12: MITIGATING LONG-TERM EFFECTS (MILE) OF RESPIRATORY DISTRESS" project. The contract was awarded under an Easy Broad Agency Announcement (EZ-BAA) issued by the Division of...
This is a $7,213,748.00 cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to The Charles Stark Draper Laboratory, Inc. (Draper), a non-profit research and development organization. The contract is for a DARPA research program with a completion date of May 15, 2026. No set-aside was used. Draper has subcontracted with Cbset, Inc., a non-profit preclinical contract research organization, and Mriglobal, a not-for-profit research organization,...
This is a $2,199,139.00 cost-plus-fixed-fee definitive contract awarded by the Food and Drug Administration (FDA) to The Charles Stark Draper Laboratory, Inc., doing business as Draper. The contract, with a period of performance through March 27, 2023, is for the development of continuous acoustic separation technology for cell therapeutic manufacturing. Draper is a non-profit research and development organization that provides specialized engineering services to the federal government,...
This is a firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to President and Fellows of Harvard College (Harvard University) for the development of a "Human Lymphoid Follicle Chip with In-Line Biomarker Sensing". The $749,000 contract was awarded on September 15, 2021, with a completion date of May 31, 2023. The contract is not set aside for any specific business type. Harvard University, a private...
This federal contract award is for $142,563.00 to Biosurfaces Inc., a for-profit vendor that provides medical and laboratory supplies, equipment, and services to the Department of Health and Human Services (HHS), primarily the National Institutes of Health (NIH). The award is for the provision of expandable lung alveolar epithelial cells in support of coronavirus (COVID-19) research conducted by the NIH's National Center for Advancing Translational Sciences. This non-competitive acquisition...
This is a $7,324,639.00 definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to President and Fellows of Harvard College, operating as Harvard University, a private non-profit educational institution. The contract, with a completion date of March 15, 2024, is for the development of human organ chips to support the evaluation of radiation countermeasures. Key subcontractors include the UK Health Security Agency and Boston Children's Hospital, who...
This is a $2,422,412.00 cost-plus-fixed-fee federal contract awarded by the Defense Threat Reduction Agency (DTRA) to The Charles Stark Draper Laboratory, Inc. (Draper), a non-profit research and development organization. The contract has no set-aside designation. Draper is providing specialized engineering, science, and technical services to support DTRA's critical defense, space, medical, and commercial programs. This includes work on guidance, navigation, control systems, sensors,...